The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk - PubMed (original) (raw)
. 2005 Nov;14(11 Pt 1):2563-8.
doi: 10.1158/1055-9965.EPI-05-0356.
James Lowey, Fredrik Wiklund, Jielin Sun, Fredrik Lindmark, Fang-Chi Hsu, Latchezar Dimitrov, Baoli Chang, Aubrey R Turner, Wennan Liu, Hans-Olov Adami, Edward Suh, Jason H Moore, S Lilly Zheng, William B Isaacs, Jeffrey M Trent, Henrik Grönberg
Affiliations
- PMID: 16284379
- DOI: 10.1158/1055-9965.EPI-05-0356
The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk
Jianfeng Xu et al. Cancer Epidemiol Biomarkers Prev. 2005 Nov.
Abstract
It is widely hypothesized that the interactions of multiple genes influence individual risk to prostate cancer. However, current efforts at identifying prostate cancer risk genes primarily rely on single-gene approaches. In an attempt to fill this gap, we carried out a study to explore the joint effect of multiple genes in the inflammation pathway on prostate cancer risk. We studied 20 genes in the Toll-like receptor signaling pathway as well as several cytokines. For each of these genes, we selected and genotyped haplotype-tagging single nucleotide polymorphisms (SNP) among 1,383 cases and 780 controls from the CAPS (CAncer Prostate in Sweden) study population. A total of 57 SNPs were included in the final analysis. A data mining method, multifactor dimensionality reduction, was used to explore the interaction effects of SNPs on prostate cancer risk. Interaction effects were assessed for all possible n SNP combinations, where n = 2, 3, or 4. For each n SNP combination, the model providing lowest prediction error among 100 cross-validations was chosen. The statistical significance levels of the best models in each n SNP combination were determined using permutation tests. A four-SNP interaction (one SNP each from IL-10, IL-1RN, TIRAP, and TLR5) had the lowest prediction error (43.28%, P = 0.019). Our ability to analyze a large number of SNPs in a large sample size is one of the first efforts in exploring the effect of high-order gene-gene interactions on prostate cancer risk, and this is an important contribution to this new and quickly evolving field.
Similar articles
- Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J, Wiklund F, Zheng SL, Chang B, Bälter K, Li L, Johansson JE, Li G, Adami HO, Liu W, Tolin A, Turner AR, Meyers DA, Isaacs WB, Xu J, Grönberg H. Sun J, et al. J Natl Cancer Inst. 2005 Apr 6;97(7):525-32. doi: 10.1093/jnci/dji070. J Natl Cancer Inst. 2005. PMID: 15812078 - Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk.
Sun J, Wiklund F, Hsu FC, Bälter K, Zheng SL, Johansson JE, Chang B, Liu W, Li T, Turner AR, Li L, Li G, Adami HO, Isaacs WB, Xu J, Grönberg H. Sun J, et al. Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):480-5. doi: 10.1158/1055-9965.EPI-05-0645. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16537705 - Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Chen YC, et al. Cancer Res. 2005 Dec 15;65(24):11771-8. doi: 10.1158/0008-5472.CAN-05-2078. Cancer Res. 2005. PMID: 16357190 - Polymorphisms in Toll-like receptor genes and risk of cancer.
El-Omar EM, Ng MT, Hold GL. El-Omar EM, et al. Oncogene. 2008 Jan 7;27(2):244-52. doi: 10.1038/sj.onc.1210912. Oncogene. 2008. PMID: 18176606 Review. - Unravelling the genetics of prostate cancer.
Edwards SM, Eeles RA. Edwards SM, et al. Am J Med Genet C Semin Med Genet. 2004 Aug 15;129C(1):65-73. doi: 10.1002/ajmg.c.30027. Am J Med Genet C Semin Med Genet. 2004. PMID: 15264274 Review.
Cited by
- Impacts of Interleukin-10 Promoter Genotypes on Prostate Cancer.
Chin YT, Tsai CL, Ma HH, Cheng DC, Tsai CW, Wang YC, Shih HY, Chang SY, Gu J, Chang WS, Bau DT. Chin YT, et al. Life (Basel). 2024 Aug 20;14(8):1035. doi: 10.3390/life14081035. Life (Basel). 2024. PMID: 39202777 Free PMC article. - Blood-Derived Biomarkers of Diagnosis, Prognosis and Therapy Response in Prostate Cancer Patients.
Balázs K, Antal L, Sáfrány G, Lumniczky K. Balázs K, et al. J Pers Med. 2021 Apr 13;11(4):296. doi: 10.3390/jpm11040296. J Pers Med. 2021. PMID: 33924671 Free PMC article. Review. - Evolution in alternating environments with tunable interlandscape correlations.
Maltas J, McNally DM, Wood KB. Maltas J, et al. Evolution. 2021 Jan;75(1):10-24. doi: 10.1111/evo.14121. Epub 2020 Dec 13. Evolution. 2021. PMID: 33206376 Free PMC article. - Interleukin 10 gene rs1800896 polymorphism is associated with the risk of prostate cancer.
Chen H, Tang J, Shen N, Ren K. Chen H, et al. Oncotarget. 2017 Aug 3;8(39):66204-66214. doi: 10.18632/oncotarget.19857. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029504 Free PMC article. - The impact of interleukin-10 (IL-10) gene 4 polymorphisms on peripheral blood IL-10 variation and prostate cancer risk based on published studies.
Men T, Yu C, Wang D, Liu F, Li J, Qi X, Yang C, Jiang W, Wei X, Li X, Wang B, Mi J, Tian G. Men T, et al. Oncotarget. 2017 Jul 11;8(28):45994-46005. doi: 10.18632/oncotarget.17522. Oncotarget. 2017. PMID: 28526808 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous